They’re very simple, acute visits. cold, COVID, influenza, pink eye, urinary tract infections. We’re able to do some skin conditions if it’s a mild or minor rash,” said Nicole Goliber, physician ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Today there are more options than ever for managing migraine effectively. Find out what might work for you with this comprehensive guide to acute and preventive prescription drugs.

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.